SCHEMBL28007152

SCHEMBL28007152

c1ccc(Oc2c[nH]c3ccccc23)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 2/20 0.51
NR4A2 P43354 1/20 0.49
NPSR1 Q6W5P4 1/20 0.46
ATM Q13315 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
GPR84 Q9NQS5 2/20 0.44
CYP3A4 P08684 1/20 0.44
MAPT P10636 1/20 0.44
AHR P35869 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
KCNT1 Q5JUK3 1/20 0.43
TUBB4A P04350 1/20 0.43
TUBB P07437 1/20 0.43
TUBA3C P0DPH7 1/20 0.43
TUBA1B P68363 1/20 0.43
TUBA4A P68366 1/20 0.43
TUBB4B P68371 1/20 0.43
TUBB3 Q13509 1/20 0.43
TUBB2A Q13885 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1979309 0.94 SLC22A6 (0.53) SLC22A6NR4A2NPSR1ATMMEN1
SCHEMBL3538344 0.87 SLC22A6 (0.58) SLC22A6NR4A2ATMMEN1KMT2A
SCHEMBL31744738 0.85 SMN1; SMN2 (0.54) SLC22A6NPSR1MEN1KMT2AGPR84
SCHEMBL27396972 0.85 RHEB (0.51) SLC22A6NPSR1ATMMAPTRHEB
SCHEMBL31744658 0.85 SLC22A6 (0.50) SLC22A6ATMMEN1KMT2AGPR84
SCHEMBL31744565 0.85 SLC22A6 (0.46) SLC22A6ATMMEN1KMT2AGPR84
SCHEMBL31744932 0.85 SLC22A6 (0.50) SLC22A6NR4A2NPSR1ATMMEN1
SCHEMBL31744699 0.81 GPR84 (0.51) SLC22A6NPSR1MEN1KMT2AGPR84
SCHEMBL4920498 0.81 STING1 (0.49) SLC22A6MEN1KMT2AGPR84MAPT
SCHEMBL31744736 0.81 STING1 (0.49) SLC22A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US claimed
US-20250382269-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US claimed
CN-117358067-A Oil-water separation film based on benzoxazine derivative, preparation method and application 陕西科技大学 2024-01-09 CN claimed
US-20250382269-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US disclosed
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US disclosed
CN-117358067-A Oil-water separation film based on benzoxazine derivative, preparation method and application 陕西科技大学 2024-01-09 CN disclosed
CN-115094423-B Inorganic membrane removing liquid suitable for aluminum substrate circuit board and application thereof 深圳市板明科技股份有限公司 2022-11-08 CN disclosed
CN-115094423-A Inorganic film removing liquid suitable for aluminum substrate circuit board and application thereof 深圳市板明科技股份有限公司 2022-09-23 CN disclosed
CN-104471771-B Sugar is completely oxidized to electric energy using cell-free synthesis enzymatic access 中国科学院天津工业生物技术研究所 2018-12-07 CN disclosed
CN-105377034-A Nematode repellent composition FMC CORP 2016-03-02 CN disclosed
CN-104471771-A Complete oxidation of sugars to electrical energy using cell-free synthetic enzymatic pathways ZHANG YI HENG PERCIVAL 2015-03-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382269-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CD14, MIF, NOD2 SLC22A6 2577/4885NR4A2 1398/4885NPSR1 2937/4885
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CD14, MIF, NOD2 SLC22A6 2577/4885NR4A2 1398/4885NPSR1 2937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.